Appropriateness of clinical criteria for the use of SYmptomatic Slow-Acting Drug for OsteoArthritis (SYSADOA). A Delphi Method Consensus initiative among experts in Italy-Reference-Cited by-同舟云学术

Appropriateness of clinical criteria for the use of SYmptomatic Slow-Acting Drug for OsteoArthritis (SYSADOA). A Delphi Method Consensus initiative among experts in Italy

Published:2019-10 Issue:5 Volume:55 Page:
ISSN:1973-9087
Container-title:European Journal of Physical and Rehabilitation Medicine
language:
Short-container-title:Eur J Phys Rehabil Med

Author:

Bernetti Andrea,Mangone Massimiliano,Villani Ciro,Alviti Federica,Valeo Massimo,Grassi Maria C.,Migliore Alberto,Viora Ugo,Adriani Ezio,Quirino Nicola,Fioravanti Antonella,Paoloni Marco

Publisher

Edizioni Minerva Medica

Subject

Rehabilitation,Physical Therapy, Sports Therapy and Rehabilitation

Link

https://www.minervamedica.it/pdf.php?cod=R33Y2019N05A0658

Reference32 articles.

1. Osteoarthritis in Europe: impact on health status, work productivity and use of pharmacotherapies in five European countries

2. Quality of osteoarthritis management and the need for reform in the US

3. Lifetime risk of symptomatic knee osteoarthritis

4. One in four people may develop symptomatic hip osteoarthritis in his or her lifetime

5. Effectiveness and safety of glucosamine and chondroitin for the treatment of osteoarthritis: a meta-analysis of randomized controlled trials

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Review of Current Approaches to Pain Management in Knee Osteoarthritis with a Focus on Italian Clinical Landscape;Journal of Clinical Medicine;2024-08-31

2. Analysis of the gut microbiome in sled dogs reveals glucosamine- and activity-related effects on gut microbial composition;Frontiers in Veterinary Science;2024-02-07

3. A Concise Review of Extraction and Characterization of Chondroitin Sulphate from Fish and Fish Wastes for Pharmacological Application;Current Issues in Molecular Biology;2022-08-28

4. Glucosamine as a Treatment for Osteoarthritis: What If It’s True?;Frontiers in Pharmacology;2022-03-17

5. Cartilage damage: clinical approach;Minerva Orthopedics;2022-03